Modular Medical, Inc. (MODD)
USD 0.97
(-6.43%)
USD 0.97
(-6.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -17.52 Million USD | -26.3% |
| 2023 | -13.87 Million USD | 7.02% |
| 2022 | -14.92 Million USD | -103.45% |
| 2021 | -7.33 Million USD | -37.19% |
| 2020 | -5.34 Million USD | -107.5% |
| 2019 | -2.57 Million USD | -286.89% |
| 2018 | -666.16 Thousand USD | -631.64% |
| 2017 | -91.05 Thousand USD | -591.72% |
| 2016 | -13.16 Thousand USD | 18.32% |
| 2015 | -16.11 Thousand USD | -49.6% |
| 2014 | -10.77 Thousand USD | 1.36% |
| 2013 | -10.92 Thousand USD | -14.79% |
| 2012 | -9513.00 USD | -3.7% |
| 2011 | -9174.00 USD | -19.64% |
| 2010 | -7668.00 USD | 18.43% |
| 2009 | -9400.00 USD | -39.96% |
| 2008 | -6716.00 USD | -3.61% |
| 2007 | -6482.00 USD | 27.22% |
| 2006 | -8906.00 USD | 37.67% |
| 2005 | -14.28 Thousand USD | -130.21% |
| 2004 | -6207.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.75 Million USD | -5.0% |
| 2024 FY | -17.52 Million USD | -26.3% |
| 2024 Q4 | -4.31 Million USD | 18.03% |
| 2024 Q2 | -4.19 Million USD | -11.7% |
| 2024 Q3 | -5.26 Million USD | -25.75% |
| 2023 FY | -13.87 Million USD | 7.02% |
| 2023 Q1 | -3.49 Million USD | 13.12% |
| 2023 Q4 | -3.57 Million USD | -6.38% |
| 2023 Q3 | -3.35 Million USD | 2.64% |
| 2023 Q2 | -3.44 Million USD | 1.43% |
| 2022 FY | -14.92 Million USD | -103.45% |
| 2022 Q1 | -3.37 Million USD | -94.69% |
| 2022 Q2 | -3.69 Million USD | -9.51% |
| 2022 Q3 | -3.83 Million USD | -3.7% |
| 2022 Q4 | -4.02 Million USD | -5.12% |
| 2021 Q2 | -1.85 Million USD | 0.8% |
| 2021 Q4 | -1.73 Million USD | 7.37% |
| 2021 Q1 | -1.87 Million USD | 2.21% |
| 2021 Q3 | -1.87 Million USD | -0.61% |
| 2021 FY | -7.33 Million USD | -37.19% |
| 2020 FY | -5.34 Million USD | -107.5% |
| 2020 Q1 | -1.13 Million USD | -11.31% |
| 2020 Q2 | -1.15 Million USD | -1.68% |
| 2020 Q3 | -1.13 Million USD | 1.86% |
| 2020 Q4 | -1.91 Million USD | -68.74% |
| 2019 FY | -2.57 Million USD | -286.89% |
| 2019 Q1 | -255.19 Thousand USD | -37.8% |
| 2019 Q2 | -548.99 Thousand USD | -115.13% |
| 2019 Q3 | -750.56 Thousand USD | -36.71% |
| 2019 Q4 | -1.02 Million USD | -36.24% |
| 2018 FY | -666.16 Thousand USD | -631.64% |
| 2018 Q3 | -260.86 Thousand USD | -47.96% |
| 2018 Q2 | -176.3 Thousand USD | -120.0% |
| 2018 Q1 | -80.13 Thousand USD | -3555.98% |
| 2018 Q4 | -185.19 Thousand USD | 29.01% |
| 2017 Q1 | -1753.00 USD | 18.16% |
| 2017 FY | -91.05 Thousand USD | -591.72% |
| 2017 Q4 | -2192.00 USD | 12.04% |
| 2017 Q3 | -2492.00 USD | 59.99% |
| 2017 Q2 | -6228.00 USD | -255.28% |
| 2016 Q4 | -2142.00 USD | 11.38% |
| 2016 Q2 | -6851.00 USD | -89.41% |
| 2016 Q1 | -3617.00 USD | 12.14% |
| 2016 Q3 | -2417.00 USD | 64.72% |
| 2016 FY | -13.16 Thousand USD | 18.32% |
| 2015 Q1 | -1742.00 USD | 18.98% |
| 2015 FY | -16.11 Thousand USD | -49.6% |
| 2015 Q2 | -4524.00 USD | -159.7% |
| 2015 Q4 | -4117.00 USD | -6.74% |
| 2015 Q3 | -3857.00 USD | 14.74% |
| 2014 Q3 | -2475.00 USD | 43.81% |
| 2014 Q1 | -2050.00 USD | 0.0% |
| 2014 Q2 | -4405.00 USD | -114.88% |
| 2014 Q4 | -2150.00 USD | 13.13% |
| 2014 FY | -10.77 Thousand USD | 1.36% |
| 2013 Q2 | -4705.00 USD | -248.52% |
| 2013 FY | -10.92 Thousand USD | -14.79% |
| 2013 Q1 | -1350.00 USD | 32.09% |
| 2013 Q4 | -2050.00 USD | 3.07% |
| 2013 Q3 | -2115.00 USD | 55.05% |
| 2012 Q1 | -2047.00 USD | -20.41% |
| 2012 FY | -9513.00 USD | -3.7% |
| 2012 Q4 | -1988.00 USD | -5.8% |
| 2012 Q3 | -1879.00 USD | 56.26% |
| 2012 Q2 | -4296.00 USD | -109.87% |
| 2011 Q2 | -3917.00 USD | -360.82% |
| 2011 Q1 | -850.00 USD | 50.29% |
| 2011 FY | -9174.00 USD | -19.64% |
| 2011 Q4 | -1700.00 USD | -12.58% |
| 2011 Q3 | -1510.00 USD | 61.45% |
| 2010 Q1 | -575.00 USD | 52.08% |
| 2010 FY | -7668.00 USD | 18.43% |
| 2010 Q4 | -1710.00 USD | -76.11% |
| 2010 Q3 | -971.00 USD | 76.53% |
| 2010 Q2 | -4137.00 USD | -619.48% |
| 2009 Q2 | -6355.00 USD | -531.08% |
| 2009 Q3 | -1270.00 USD | 80.02% |
| 2009 Q4 | -1200.00 USD | 5.51% |
| 2009 FY | -9400.00 USD | -39.96% |
| 2009 Q1 | -1007.00 USD | -17.37% |
| 2008 Q3 | -940.00 USD | 75.97% |
| 2008 FY | -6716.00 USD | -3.61% |
| 2008 Q4 | -858.00 USD | 8.72% |
| 2008 Q2 | -3911.00 USD | -6961.4% |
| 2008 Q1 | 57.00 USD | 104.83% |
| 2007 FY | -6482.00 USD | 27.22% |
| 2007 Q2 | -3567.00 USD | -285.62% |
| 2007 Q3 | -1792.00 USD | 49.76% |
| 2007 Q4 | -1180.00 USD | 34.15% |
| 2007 Q1 | -925.00 USD | 41.05% |
| 2006 Q4 | -1569.00 USD | -10.81% |
| 2006 Q2 | -4996.00 USD | -36.84% |
| 2006 FY | -8906.00 USD | 37.67% |
| 2006 Q1 | -3651.00 USD | -105.57% |
| 2006 Q3 | -1416.00 USD | 71.66% |
| 2005 FY | -14.28 Thousand USD | -130.21% |
| 2005 Q3 | -4544.00 USD | -5.23% |
| 2005 Q2 | -4318.00 USD | 0.0% |
| 2005 Q4 | -1776.00 USD | 60.92% |
| 2004 FY | -6207.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -22.06% |
| Cerus Corporation | -30.05 Million USD | 41.673% |
| OrthoPediatrics Corp. | -25.76 Million USD | 31.968% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -65.036% |
| Talis Biomedical Corporation | -66.81 Million USD | 73.765% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -1.347% |
| Inogen, Inc. | -109.38 Million USD | 83.975% |
| Spectral AI, Inc. | -12.98 Million USD | -35.005% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 71.993% |
| CVRx, Inc. | -43.1 Million USD | 59.332% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -396.854% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -41.044% |
| Orthofix Medical Inc. | -139.11 Million USD | 87.399% |
| Venus Concept Inc. | -28.3 Million USD | 38.08% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 67.556% |
| Bioventus Inc. | -81.72 Million USD | 78.551% |
| BrainsWay Ltd. | -4.92 Million USD | -255.774% |
| Envoy Medical, Inc. | -18.37 Million USD | 4.583% |
| electroCore, Inc. | -18.8 Million USD | 6.785% |
| IceCure Medical Ltd | -15.57 Million USD | -12.539% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 63.844% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -1.511% |
| MaxCyte, Inc. | -48.29 Million USD | 63.707% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -46.622% |
| Nexalin Technology, Inc. | -5.69 Million USD | -207.726% |
| PAVmed Inc | -68.79 Million USD | 74.52% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 69.01% |
| RxSight, Inc. | -50.08 Million USD | 65.001% |
| Sight Sciences, Inc. | -57.27 Million USD | 69.394% |
| SI-BONE, Inc. | -46.93 Million USD | 62.649% |
| TELA Bio, Inc. | -44.07 Million USD | 60.229% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 67.629% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 65.915% |
| LivaNova PLC | -68.49 Million USD | 74.409% |
| 908 Devices Inc. | -42.75 Million USD | 59.004% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 89.891% |
| Nemaura Medical Inc. | -9.59 Million USD | -82.684% |
| NeuroPace, Inc. | -27.17 Million USD | 35.493% |
| LENSAR, Inc. | -12.22 Million USD | -43.34% |
| Apyx Medical Corporation | -17.25 Million USD | -1.564% |
| Cutera, Inc. | -156.23 Million USD | 88.78% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -103.731% |
| BioSig Technologies, Inc. | -28.51 Million USD | 38.521% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 79.999% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 21.906% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 115.717% |
| Axonics, Inc. | -26.05 Million USD | 32.728% |
| Outset Medical, Inc. | -169.77 Million USD | 89.675% |
| IRIDEX Corporation | -10 Million USD | -75.167% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 83.943% |
| IRadimed Corporation | 20.03 Million USD | 187.49% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -112.602% |
| INVO Bioscience, Inc. | -6.76 Million USD | -159.031% |
| Telesis Bio, Inc. | -35.15 Million USD | 50.131% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 222.324% |
| Varex Imaging Corporation | 32.1 Million USD | 154.607% |
| Quipt Home Medical Corp. | 3.91 Million USD | 547.282% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -44.474% |
| Pulmonx Corporation | -61.93 Million USD | 71.698% |
| Dynatronics Corporation | -2.27 Million USD | -671.167% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -19.742% |
| Semler Scientific, Inc. | 22.25 Million USD | 178.761% |
| InMode Ltd. | 195.66 Million USD | 108.959% |
| Bruker Corporation | 436.9 Million USD | 104.012% |
| Cytosorbents Corporation | -31.2 Million USD | 43.834% |
| DexCom, Inc. | 597.7 Million USD | 102.933% |
| Align Technology, Inc. | 643.33 Million USD | 102.725% |
| Viveve Medical, Inc. | -21.55 Million USD | 18.67% |
| ZimVie Inc. | -30.93 Million USD | 43.343% |
| Movano Inc. | -29.69 Million USD | 40.96% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 37.048% |
| Nexalin Technology, Inc. | -5.69 Million USD | -207.726% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -396.854% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 92.484% |
| Profound Medical Corp. | -28.61 Million USD | 38.744% |
| Insulet Corporation | 220 Million USD | 107.968% |
| enVVeno Medical Corporation | -25.23 Million USD | 30.545% |
| Surmodics, Inc. | -5.64 Million USD | -210.523% |
| iCAD, Inc. | -7.68 Million USD | -127.975% |
| Nuwellis, Inc. | -17.63 Million USD | 0.573% |
| Biotricity, Inc. | -8.82 Million USD | -98.555% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 85.995% |
| Aethlon Medical, Inc. | -12.63 Million USD | -38.716% |
| InspireMD, Inc. | -21.14 Million USD | 17.093% |
| PAVmed Inc. | -68.79 Million USD | 74.52% |
| BIOLASE, Inc. | -17.93 Million USD | 2.275% |
| Beyond Air, Inc. | -63 Million USD | 72.179% |
| FONAR Corporation | 16.53 Million USD | 206.009% |
| AxoGen, Inc. | -21.46 Million USD | 18.325% |
| Vivani Medical, Inc. | -26.96 Million USD | 34.994% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 197.162% |
| Inari Medical, Inc. | -14.03 Million USD | -24.922% |
| UFP Technologies, Inc. | 57.66 Million USD | 130.399% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -255.731% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -177.983% |
| Tenon Medical, Inc. | -15.72 Million USD | -11.458% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -134.533% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 58.954% |
| AdaptHealth Corp. | -598.4 Million USD | 97.071% |
| Sintx Technologies, Inc. | -13.35 Million USD | -31.225% |
| NanoVibronix, Inc. | -3.43 Million USD | -410.157% |
| Quanterix Corporation | -49.7 Million USD | 64.731% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -44.474% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -4488.743% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 94.759% |
| TransMedics Group, Inc. | -28.72 Million USD | 38.981% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 25.762% |
| NeuroMetrix, Inc. | -7.15 Million USD | -145.109% |
| Hyperfine, Inc. | -48.11 Million USD | 63.569% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 73.043% |
| Biomerica, Inc. | -6.36 Million USD | -175.31% |
| Bone Biologics Corporation | -9.42 Million USD | -85.919% |
| AVITA Medical, Inc. | -40.4 Million USD | 56.614% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -69.999% |
| Silk Road Medical, Inc | -59.27 Million USD | 70.426% |